Sterne Agee Initiates Boston Scientific At Neutral
Sterne Agee initiated coverage on shares of Boston Scientific (NYSE: BSX) with a Neutral rating.
The target price for Boston Scientific is set to $13.50.
Boston Scientific shares have surged 19.76% over the past 52 weeks, while the S&P 500 index has gained 17.38% in the same period.
Boston Scientific's shares dropped 1.07% to close at $12.97 yesterday.
Latest Ratings for BSX
|Jan 2015||Leerink Swann||Upgrades||Market Perform||Outperform|
|Oct 2014||Goldman Sachs||Upgrades||Sell||Neutral|
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.